Sign in
4

Changes in Ownership

ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000033

CEO bought 374,200 shares at an average $0.01 ($3,797)

From the SEC's structured data for this filing

Trades in this filing

Collier Alan Brian · CEO

Table I: Non-derivative

26 lines
Date Transaction Shares Price Value Owned after D/I
2019-05-22 Purchase : show line 1 in the form +5,000 $0.01 $54 22,925,397 D
2019-05-22 Purchase : show line 2 in the form +2,000 $0.01 $22 22,927,397 D
2019-05-22 Purchase : show line 3 in the form +25,000 $0.01 $260 22,952,397 D
2019-05-22 Purchase : show line 4 in the form +10,000 $0.01 $104 22,962,397 D
2019-05-22 Purchase : show line 5 in the form +2,000 $0.01 $23 22,964,397 D
2019-05-22 Purchase : show line 6 in the form +5,000 $0.01 $56 22,969,397 D
2019-05-22 Purchase : show line 7 in the form +20,000 $0.01 $224 22,989,397 D
2019-05-22 Purchase : show line 8 in the form +5,000 $0.01 $53 22,994,397 D
Open-market purchases · 374,200 sh · avg $0.01 · $3,797
Loading xslF345X03/primary_doc.xml…